Abstract
Metabolic Engineering (ME) provides the know-how for the reconstruction of microorganisms, in order to provide higher production rates of biotechnological products and increase their potential application in several industries, particularly those pharmaceutical, food and environmental. However, microbial metabolic cell reconstruction has limitations. Metabolic Control Analysis (MCA) allows the evaluation of the reliability of the changes performed by ME, emphasizing the importance of the whole pathways rather than individual pathway reactions resulting from simple flux analysis. This led to an increased emphasis on the regulatory structure of the network. The use of MCA becomes indispensable to quantify metabolic parameters, particularly those related with direct genetic modifications. However, this type of analysis is not a common practice. In the present study MCA is exemplified as a tool of ME, being demonstrated its practical application in drug delivery and in the production of three relevant biotechnological products (penicillin V, llysine and glycerol).
Keywords: Control coefficient, drug delivery, enzyme, glycerol, kinetics, l-lysine, metabolic control analysis, penicillin V.
Current Bioinformatics
Title:Metabolic Control Analysis and its Applications
Volume: 9 Issue: 5
Author(s): Ana Meireles and Manuel Simoes
Affiliation:
Keywords: Control coefficient, drug delivery, enzyme, glycerol, kinetics, l-lysine, metabolic control analysis, penicillin V.
Abstract: Metabolic Engineering (ME) provides the know-how for the reconstruction of microorganisms, in order to provide higher production rates of biotechnological products and increase their potential application in several industries, particularly those pharmaceutical, food and environmental. However, microbial metabolic cell reconstruction has limitations. Metabolic Control Analysis (MCA) allows the evaluation of the reliability of the changes performed by ME, emphasizing the importance of the whole pathways rather than individual pathway reactions resulting from simple flux analysis. This led to an increased emphasis on the regulatory structure of the network. The use of MCA becomes indispensable to quantify metabolic parameters, particularly those related with direct genetic modifications. However, this type of analysis is not a common practice. In the present study MCA is exemplified as a tool of ME, being demonstrated its practical application in drug delivery and in the production of three relevant biotechnological products (penicillin V, llysine and glycerol).
Export Options
About this article
Cite this article as:
Meireles Ana and Simoes Manuel, Metabolic Control Analysis and its Applications, Current Bioinformatics 2014; 9 (5) . https://dx.doi.org/10.2174/1574893609666140515230435
DOI https://dx.doi.org/10.2174/1574893609666140515230435 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Novel Coronavirus SARS-CoV-2 (COVID-19) and Pregnancy: A Hypothetical View
Endocrine, Metabolic & Immune Disorders - Drug Targets Diabetes without Manifest Cardiovascular Disease: A Novel Approach in Risk Stratification and Treatment Selection
Current Diabetes Reviews Radiocontrast Nephropathy: Progress not Prevention
Current Cardiology Reviews Sirtuins: Novel Players in Male Reproductive Health
Current Medicinal Chemistry Control of Mycobacterium tuberculosis Infection by Glutathione
Recent Patents on Anti-Infective Drug Discovery Burkholderia Cepacia Complex Causing Pneumonia in an Immunocompetent Non-Cystic Fibrosis Patient: Case Report and Review of Literature
Infectious Disorders - Drug Targets Role of Connexins and Pannexins in Ischemic Stroke
Current Medicinal Chemistry A Review on Molecular Mechanisms and Patents of Marine-derived Anti-thrombotic Agents
Current Drug Targets Cellular Senescence in Cardiovascular Diseases: Potential Age-Related Mechanisms and Implications for Treatment
Current Pharmaceutical Design Cardiorenal Consequences of Atherosclerosis and Statins Therapy: From the Past to the Future
Current Pharmaceutical Design Genetic and Molecular Approaches to the Immunopathogenesis of Multiple Sclerosis: An Update
Current Molecular Medicine Pharmacokinetic Study and Trial for Preparation of Enteric-Coated Capsule Containing Insulinomimetic Vanadyl Compounds: Implications for Clinical Use
Mini-Reviews in Medicinal Chemistry Acute Cardioembolic Cerebral Infarction: Answers to Clinical Questions
Current Cardiology Reviews The Metformin Paradox
Current Diabetes Reviews Lycopene and Cardiovascular Diseases: An Update
Current Medicinal Chemistry Editorial:Nutrition Transition in Developing Countries: Focus on South Asia
Current Diabetes Reviews Pioglitazone Prevents Smoking Carcinogen-Induced Lung Tumor Development in Mice
Current Cancer Drug Targets Nonalcoholic Fatty Liver Disease: The Pathogenetic Roles of Insulin Resistance and Adipocytokines
Current Molecular Medicine The Insulin-sensitizing Role of the Fat Derived Hormone Adiponectin
Current Pharmaceutical Design Controversies in Anticoagulant Therapy in Vitreo-Retinal Surgery
Current Pharmaceutical Design